mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.0003 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.42 |
0.0008 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |